Pyrrolopyridine-2-carboxylic acid amide inhibitors of glycogen phosphorylase
CA 2525502 C · Owner: Rowley, Robert John · Inventors: Sambrook Smith, Colin Peter; Schofield, Karen Lesley; Murray, Peter John
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Compounds represented by Formula (I): or pharmaceutically acceptable salts thereof, are inhibitors of glycogen phosphorylase and are useful in the prophylactic or therapeutic treatment of diabetes hyperglycemia, hypercholesterolemia, hyperinsulinemia hyperlipidemia, hypertension, atherosclerosis or tissue ischemia e.g. myocardial ischemia and as , cardioprotectants.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed May 20, 2004 and granted December 18, 2012. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended May 20, 2024.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by May 20, 2026.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.